Cognitive behavioral therapy for psychosis (CBTp) involves helping patients to understand and reframe threatening appraisals of their psychotic experiences to reduce distress and increase functioning. Whilst CBTp is effective for many, it is not effective for all patients and the factors predicting a good outcome remain poorly understood. Machine learning is a powerful approach that allows new predictors to be identified in a data-driven way, which can inform understanding of the mechanisms underlying therapeutic interventions, and ultimately make predictions about symptom improvement at the individual patient level.
Introduction
The functional neurobiological underpinning of positive psychotic and affective symptoms in schizophrenia has been extensively studied [1] [2] [3] [4] [5] [6] [7] [8] [9] and there is considerable promise in using these neurobiological markers to improve the precision of interventions at the individual patient level 10 . To date, four studies have examined the neural predictors of cognitive behavioral therapy for psychosis (CBTp) treatment outcomes [11] [12] [13] [14] , the primary psychological intervention for this patient group 15 . However, none of these studies used machine learning methods to investigate neural predictors at the individual patient level. Currently, only three studies have made successful predictions about individual CBT treatment outcomes using such analytical approaches, none of which was in schizophrenia patients [16] [17] [18] . However, individual predictions are an important step towards better tailoring of treatment by utilising patient-specific markers to provide an objective estimate of treatment outcomes.
Incorporation of neural predictors into existing assessment procedures can inform clinical decision-making regarding the use of additional psychological therapies to improve treatment effectiveness 19 and the resources that support CBTp. This is crucial considering that only approximately 50% of patients may experience clinically significant improvement following CBTp 20 and limited clinical service resources mean that, even in the UK where it is a NICE 21 -recommended treatment, only approximately 10% of patients receive therapy in routine services 22 .
Supervised machine learning methods, such as multivariate pattern analysis, are a powerful tool for identifying the neural predictors of treatment response since the analysis involves building an algorithm that can make predictions at the individual patient level 23 . This data-
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driven approach can detect subtle patterns of distributed activity predicting clinical outcomes 23 , such as treatment outcomes or disorder course. Brain responses to clinically relevant stimuli may be most likely to yield meaningful predictions about symptom improvement. A highly replicated finding in psychosis is a bias towards perceiving facial expressions as threatening, including evidence for the misattribution of threat to neutral facial expressions 24, 25 , which has been put forward as one route to paranoia [25] [26] [27] . Neuroimaging markers for this bias include elevated responses in a number of regions involved in threat perception and emotion processing 24, 28, 29 . This network includes a number of limbic regions, including the amygdala, hippocampus and insula, as well as visual and motor areas 28, 30, 31 .
The amygdala and insula are part of the ventral network which includes the anterior cingulate and the ventrolateral prefrontal cortex (PFC), whereas the hippocampus belongs to the dorsal system which includes the dorsolateral and dorsomedial PFC 25 . The latter is involved in the regulation of emotions whereas the former is important for threat appraisal 25, 32 . Sensorimotor regions, together with frontal regions, are crucial for the development of behavioural responses in a context-dependent matter 33 . Neuroimaging studies on affective face processing have reported reduced activation in frontal areas, but increased activation in threat and sensorimotor regions in patients with psychosis in comparison to healthy controls 28, 29 . In particular, the misattribution of threat to neutral stimuli has been associated with increased activation in the precentral and postcentral gyrus as well as the parietal lobule 34 . Elevated threat-related activity in response to neutral facial expressions suggests they are not neutral in psychosis, which seems consistent with the interpretation of a heightened tendency to perceive threat when facial expressions are ambiguous 24, 25, 27 . The evidence for increased activation for both ambiguous and threatening affect suggests the facial affect task is highly sensitive to aberrant threat and salience processing in psychosis. Additionally, evidence for reduced brain activation responses to happy facial expressions in major depression 35, 36 
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suggests the task is sensitive to altered processing of prosocial affect in those who experience depressive symptoms. Moreover, differences in task activation have been shown to relate to both the type and severity of symptoms 37, 38 , making the facial affect task a potential assay for predicting post-therapy improvement in psychotic and affective symptoms.
CBTp is an effective intervention for psychosis 39 and is accompanied by improvements in social, occupational, and psychological functioning 20, 40 . The primary aim of CBTp is helping patients to understand and reframe threatening appraisals of their psychotic experiences, become less distressed and live a personally meaningful life 41, 42 . Affective symptoms are frequently reported in psychosis 43 and are a common target of therapy by emphasising techniques that help patients recognise and change mood-congruent biases and unhelpful thinking styles 41, 44 , with evidence of reduced depression following CBTp 45, 46 . One neural mechanism proposed to underlie treatment effects in CBTp involves an increased recruitment of higher-order brain networks to regulate brain regions involved in threat and salience perception 47 . This has been probed experimentally using the facial affect processing task, which has shown that improvement in positive psychotic symptoms 47, 48 and depressive symptoms 47 correlates with changes in functional neurobiology [47] [48] [49] . In particular, CBTp-led reductions in activation of the threat network in response to affective stimuli 48 and concomitant increases in connectivity between the left amygdala and inferior parietal lobule correlated with improvement in positive symptoms of psychosis 47 . These post-CBTp connectivity changes between the amygdala and the inferior parietal lobule as well as the dorsolateral PFC have also been found to be predictive of long-term affective and psychotic symptoms across several years 49 . Whilst these studies have provided insight into the neural mechanisms underlying therapeutic change, they have not provided neural predictors of treatment outcomes for individual patients. The dorsolateral PFC might be a particularly
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T
promising region, since increased activity in this area in response to a working memory task predicted good outcomes following CBTp 12 . Additionally, activation in networks including the amygdala and parietal lobule, which have been implicated in the neural mechanism of CBTp, have been found to predict individual response to CBT for social anxiety disorder 16 .
However, no study to date has examined whether pre-therapy neural responses to facial affect can be used to make individual predictions about CBTp outcomes.
The present study used the dataset of a case-controlled study that previously found that CBTp led to significant changes in the functional neurobiology of social threat processing, compared to treatment-as-usual 48 . Here, we employ multivariate pattern analysis to identify predictors of response to CBTp from pre-therapy functional MRI. We employed a two-step methodology. The first step involved identification of potentially predictive regions and the second step involved formation of a predictive model that utilised region-specific activation patterns to make a function that can make predictions at the individual patient level. We examined all available forms of facial affect processing, allowing the machine learning model to identify the specificity of the activation patterns for each facial condition for predicting treatment response in different symptom domains. We hypothesised that improvement in positive psychotic symptoms and depressive symptoms would be uniquely predicted by neural responses to threat-related (including ambiguous 'neutral' faces in addition to angry and fearful faces) and prosocial affect (happy faces), respectively. Caveated by the datadriven approach and the absence of studies investigating predictors of CBTp outcomes from social affective neural processing, we hypothesised that the dorsolateral PFC and the amygdala, suggested to be implicated in the neurobiological mechanism underlying CBTp 47 , would predict post-CBTp improvement in both positive psychotic and affective symptoms.
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Materials & methods
Participants & design
Participants were 38 patients who received either treatment-as-usual (TAU group) or CBTp on top of their regular care (+CBTp group), in a case-control cohort study described in detail elsewhere (see 48 ). This previous study identified changes both in symptoms and in neurobiology in the +CBTp group (n=22) that were not found in the TAU group (n=16). The present study focused on the +CBTp group and the TAU group was used for validation of the predictive model in an independent sample. Diagnosis was established at baseline using the Structured Clinical Interview for DSM-IV (SCID) 50 . Symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS) 51 for psychotic symptoms and the Beck Depression Inventory (BDI) 52 for depressive symptoms. All participants were scanned at the start of the study. Symptoms were reassessed after approximately six to eight months of TAU or TAU +CBTp. All participants were taking a stable dose of antipsychotic medication for a minimum of three months before the start of the study, which remained unchanged during the study. 
Functional MRI task
A detailed description of the task and functional MRI acquisition can be found in the original study 48 . Participants performed an implicit facial affect task during the scanning session, in
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which they were presented with monochrome faces portraying fear (signalling sources of threat in the environment, i.e. indirect threat), anger (direct threat), happiness (prosocial affect), or neutral (ambiguous threat) expressions 48 . Participants had to press a button to indicate the gender of the face upon each facial presentation. The task was set up as a block design. Each block consisted of 8 trials in which the same facial expression was presented (3.75 s per face, 30 seconds in total). Participants were presented with four blocks of each condition (i.e. fearful, angry, happy, and neutral faces), fully counterbalanced. Between these blocks there were 4 baseline trials in which empty oval frames matched for luminance but without the face inside were shown (3.75 s per oval frame), and a left/right button press was required on each trial.
Functional MRI data acquisition and analysis
Data were collected on a widely available 1.5 Tesla General Electric Signa clinical system 
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Activation associated with baseline symptoms
To optimize accuracy and generalisability of model predictions, feature reduction techniques were employed before training of the machine learning model 54 . Feature selection involves selecting voxels that are considered informative and excluding those considered less or noninformative about predictions, resulting in less noise and increased predictive power. We constrained our analyses 16, 55 to symptom-locked activation, given our focus on predicting symptom improvement. We also report an unconstrained (whole-brain) analysis in the Supplementary Materials. In a first step, univariate regression analysis was used to identify clusters associated with baseline positive psychotic and depressive symptoms, with baseline symptom scores being regressed separately onto activation for each facial condition. The regions included in the functionally defined masks are presented in the Supplementary Tables   1 and 2 . Functional masks were identified in the +CBTp group, which were then also independently evaluated in the separate TAU group, using a voxel-wise threshold of p < 0.001 with a cluster size of at least 10 active voxels 56 . The resulting masks were used to constrain the multivariate pattern analysis that involved building of a predictive model at the group level to make predictions about symptom change (from pre-to post-intervention) at the individual patient level.
Predicting symptom improvement following CBTp
Multivariate regression models for neuroimaging data decode patterns of voxel values from the input images that continuously predict variability in the predicted variable 53 . Here, the inputs were contrast images for neutral, angry, fearful and happy faces to predict (SD=1.7) years of education. Fourteen participants were on atypical and 2 were on both atypical and typical antipsychotics. Both patient groups showed high gender discrimination accuracy (84.7%) across all conditions (i.e. fearful, angry, happy, and neutral faces) 48 .
Performance was comparable to healthy controls, reported separately 47 . Depressive symptoms were frequently experienced in addition to positive psychotic symptoms, with over 65% of participants experiencing symptoms in the mild to severe range. From pre-therapy to post-therapy time points, both groups showed variation in positive psychotic (+CBTp M=3.2, SD=3.9; TAU M=0.5, SD=4.0) and in depressive symptom scores (+CBTp M=5.3, SD=10.9, TAU M=0.1, SD=6.9). However, symptoms improved significantly in the +CBTp group only (Table 1) .
Improvement in positive psychotic symptoms was uniquely predicted by activation elicited by all types of threat-related affect (i.e. ambiguous 'neutral' faces that are often perceived as
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threatening in psychosis, in addition to angry, and fearful faces) (r=0.63, p=0.003) ( Table 2) .
Activation in frontal, sensorimotor, and hippocampal regions contributed most strongly to the predictive model (Table 3 ). However, the profile of activation was confined to fewer regions for angry and fearful faces compared to the more widespread profile of activation for neutral faces ( Supplementary Table 3 ). Activation elicited by neutral faces contributed most strongly to the model followed by equivalent contributions from activation for angry and fearful faces ( Figure 1 ). Follow-up analyses of models including only one facial condition revealed that activation elicited by angry, fearful, and neutral faces was predictive of improvement in positive psychotic symptoms, but activation elicited by happy faces was not (Supplementary Table 4 ).
Improvement in depressive symptoms was uniquely predicted by activation elicited by fearful and happy faces (r=0.31, p=0.05) ( Table 2 ). Activation in frontal and motor regions contributed most strongly to the predictive model (Table 3) . Activation in the superior frontal gyrus solely contributed to the predictive model for fearful faces whereas a widespread pattern of activation across frontal, sensorimotor, limbic, and occipital regions contributed to the predictive model for happy faces (Supplementary Table 5 ). Activation elicited by fearful faces contributed most strongly to the model followed by activation for happy faces ( Figure   2 ). Follow-up analyses of models including only one facial condition revealed that activation elicited by fearful and happy faces was predictive but activation elicited by neutral faces was not ( Supplementary Table 4 ). Activation elicited by angry faces could not be assessed since no activation was associated with symptoms at baseline.
Assessment of predictive models in independent treatment-as-usual group
The assessment of the predictive models in the TAU group revealed that changes in both positive psychotic (r=-0.39, p=0.46) and depressive symptoms (r=-0.05, p=0.31) following TAU could not be predicted using the multiple kernel learning model (Table 4 ). Whilst the pattern was similar in terms of which facial conditions predicted changes in positive psychotic and depressive symptoms, with activation for neutral and fearful faces being the strongest predictor for changes in positive psychotic and depressive symptoms, respectively, the overall model did not reach significance ( Supplementary Figure 1, 2) .
Discussion
This proof-of-concept study set out to establish novel predictors from neural processing of social affective information by applying multivariate pattern analysis to pre-treatment functional MRI data. This research strategy bridges the gap between studies revealing associations between brain changes and CBTp outcomes 61 and potentially clinically useful biomarkers that can inform understanding of treatment mechanisms and provide a step towards predictions of outcome and treatment planning for individual patients. The findings showed, to our knowledge for the first time, that machine learning methods can be used to build a model that can predict response to CBTp for each patient from pre-therapy neural responses to social affective information. In line with our hypotheses, we found a double dissociation between the valence of social affective information and the type of symptoms predicted. Whereas the brain activation pattern in response to angry (direct threat) and neutral (ambiguous threat) faces uniquely predicted improvement in positive psychotic symptoms,
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T
the brain activation pattern in response to happy faces (prosocial affect) uniquely predicted improvement in depressive symptoms. In contrast, neural responses to fearful faces (indirect threat) predicted improvement in both positive psychotic and depressive symptoms.
These findings also highlight the potential for this approach to inform clinical decisionmaking. Caveated by a need for more research with larger samples, it may be possible to use limited predicted symptom improvement for a given patient to better tailor their treatment plan. One possibility is that CBTp may be augmented with other interventions 19 .
Alternatively, it may be possible to use baseline neurobiological responses to social affect to plan and tailor the focus of therapy, such as spending more time engaging the client or a specific focus on modifying bias towards threatening social information. Considering the protracted duration of psychological therapy in which clinical signs of improvement may not be apparent for many weeks from the start of therapy, a robust biomarker may also act as an incentive to motivate the patient and increase compliance in addition to increasing the response rate in a stratified population. The clinical promise of this approach is underlined by the finding that clinically relevant stimuli can be used as assays for making specific predictions about different symptom domains and is supported by the growing interest in machine learning to optimise treatment outcomes 16, 62, 63 .
It is interesting that processing of ambiguous 'neutral' faces was a stronger predictor of treatment response for positive psychotic symptoms than more directly threatening angry faces. One possible explanation for this finding is that processing of ambiguous stimuli particularly involves activation related to appraisals that are re-framed as part of CBTp.
Namely, ambiguous stimuli have sensory characteristics that are less defined, thereby
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allowing appraisals to have a stronger influence on their perception and interpretation.
Evidence suggests that patients with psychosis appraise even mildly anomalous experiences as more threatening compared to healthy individuals, remitted patients, and individuals with similar psychotic experiences but without a need for care [64] [65] [66] . Therefore, processing of ambiguous stimuli might most strongly reflect threatening appraisals. Neural evidence for an over-or misattribution of threat involves elevated activation to neutral or ambiguous stimuli 24, 25, 67 , which has been attributed to aberrant salience perception 68 . This suggests that neutral or ambiguous stimuli may convey subtle information to which patients with psychosis are particularly sensitive, resulting in brain responses to ambiguous facial expressions not only reliably differentiating patients from healthy controls 24 but also those who will respond well from those who will respond poorly. Processing of ambiguous stimuli might therefore most strongly reflect threatening appraisals. Since recent studies have shown that appraisals of symptoms mediate changes in outcome 69 the finding that threat-related activation, in particular, activation in response to ambiguous 'neutral faces', predicted improvement in positive psychotic symptoms suggests that CBTp most likely improves psychotic symptoms in those endorsing more threatening appraisals of neutral or ambiguous stimuli 25 . However, this claim is at present speculative and requires more sophisticated measures to be substantiated.
Brain activation in response to prosocial affect (happy faces) was unique in predicting improvement in depressive symptoms and not positive psychotic symptoms. However, brain activation in response to fearful faces emerged as an additional, and stronger, predictor of improvement in depressive symptoms than brain activation in response to happy faces.
Enhanced brain responses to fearful faces were found to be associated with baseline depressive symptoms in this clinical group 9 and reduced following CBTp in previous
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analyses 48 . Additionally, the finding that processing of both happy and fearful faces could predict improvement in depressive symptoms is in line with neuroimaging studies revealing both hypo-responses to positive and hyper-responses to negative facial expressions in depression 36 . These findings suggest that CBTp most likely improves depressive symptoms in those with mood-congruent processing biases that are reduced by exploring the impact of thoughts and behaviours on depressive symptoms.
Supporting our predictions, activity in the dorsolateral prefrontal cortex was important for predicting improvement in both positive psychotic and depressive symptoms. However, contrary to our hypothesis, the hippocampus emerged as a stronger predictor of improvement in positive psychotic symptoms than the amygdala. The dorsolateral prefrontal cortex and hippocampus are part of the dorsal system, which is involved in the regulation of emotions 27 .
The predictive power of activation in the dorsal system supports the idea that CBTp may Together, these findings suggest that a combination of threat-regulation and action preparation, as well as higher-order cognitive processes are key to predicting improvement in positive psychotic and depressive symptoms.
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Whilst the dorsolateral PFC was an important predictor of symptom improvement, it was not a stronger predictor than a large number of regions across sensorimotor and midbrain regions.
One possibility is that the present task did not actively recruit higher-order cognitive processes such as reappraisal because participants were not explicitly prompted to process the affective component of the stimuli. Additionally, these findings need to be caveated by the focus on symptom-locked activation, which omitted other areas from the analysis. A Supplementary whole-brain analysis addressed this issue, and although the pattern was similar in terms of which facial conditions predicted changes in symptoms, the overall model did not reach significance (Supplementary Table 6 , 7). Despite these constraints, the finding that activation in the dorsal system, including the dorsolateral PFC and hippocampus, was important for predicting improvement in positive psychotic symptoms, supports the idea that CBTp facilitates reappraisal through resources in higher-order brain regions that regulate those involved in threat and salience detection 47 .
Although the present study successfully predicted symptom improvement, future studies including additional measurements would provide more encompassing predictions of treatment effects. The PANSS as an instrument has been criticised for only providing a measure of the presence and severity of psychotic symptoms, rather than the considerable variation in impact and quality of these experiences across individuals 41 . This is in line with previous work, which has shown that CBTp-led changes in brain responses to indirect threat were uncorrelated with the PANSS 48 . Future studies should explore measures that consider symptom dimensions such as power beliefs and distress to provide further insight into the predictors of treatment outcomes. Additionally, there is promise in exploring whether threat
processing as a predictor is a state or trait marker. State and trait features are likely to influence the development and maintenance of threatening appraisals along different pathways, including attentional, attributional, and reasoning biases as well as safety behaviours 27 . Elucidating these features might help guide effective treatment strategies at the individual patient level.
Whilst the model identified predicted response to CBTp, it did not predict response in the independent TAU group. Caveated by the limited change in symptoms in the TAU group, these results may speak to the specificity of the findings in predicting response to CBTp rather than symptom changes per se. Future research with two active treatment groups can provide further insight into the specific predictors of response to CBTp. Additionally, the specificity of the facial conditions for predicting improvement in different symptom domains is further underlined by the similar contribution of the facial conditions to predictions in the +CBTp and independent TAU group ( Supplementary Figure 1, 2) .
Although the sample size of the present study is comparable to other machine learning studies in psychiatry 16, 55, 70 , future studies with larger samples are warranted. The patient group reported here is likely to be representative of routine clinical practice, having been recruited from a clinic as part of routine care. However, further research with larger and independent samples of patients receiving CBTp should be undertaken to further establish the utility of machine learning approaches to predicting treatment response. Additionally, the use of higher resolution functional MRI to investigate subcortical predictors should be further explored as well as the inclusion of behavioural and clinical measures into predictive models
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considering that the most optimal predictions likely require different sources of information 71 .
In summary, the present study supports the utility of machine learning methods to predict how people will respond when offered CBTp. The clinical utility of this approach is further underscored by the finding that neural responses to threat-related affect (i.e. ambiguous Machine learning methods may therefore become a valuable tool for mapping the neural correlates of these biases to make predictions about treatment outcomes for each patient. This promising approach may be further refined, for example by including additional predictors, such as structural and connectivity measures. It is our hope that these methods may ultimately go beyond treatment selection and be used to tailor and refine the psychological intervention offered to individual patients.
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internet-delivered cognitive behavior therapy for social anxiety disorder using fMRI and support vector machine learning. 
Neutral faces (ambiguous threat). Angry faces (direct threat). Fearful faces (indirect threat).
Happy faces (prosocial affect). a No predictors for angry faces because no symptom-locked activity at baseline.
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Highlights  Machine learning models using neuroimaging data can predict response to CBTp.  Neural responses to social threat predicted improvement in psychotic symptoms.  Activation related to different social stimuli predicted distinct symptom domains.  Predictors included activity in the hippocampus, frontal, and sensorimotor regions. 
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